ACE2 Is a Prognostic Biomarker and Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma: Implication for COVID-19

Figure 7

Genetic alteration of ACE2 in KIRC patients (cBioPortal). (a) OncoPrint visual summary of alteration on ACE2 in KIRC. (b) The missense mutation of ACE2 amino acids was analyzed. Color images are available online. (c) The overall survival in cases with/without ACE2 alterations.

(a)

(b)

(c)